Bleeding risk during oral anticoagulation therapy for atrial fibrillation

被引：2
|
作者：
Gallego, Pilar [1 ,2 ]
Lip, Gregory Y. H. [1 ]
Lane, Deirdre A. [1 ]
机构：
[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England
[2] Morales Meseguer Univ Hosp, Dept Hematol & Clin Oncol, Murcia, Spain
来源：
EUROPACE | 2013年 / 15卷 / 06期
关键词：
NET CLINICAL BENEFIT; MANAGEMENT; WARFARIN; GUIDELINES;
D O I：
10.1093/europace/eut061
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 774
页数：2
相关论文
共 50 条
  • [21] Low bleeding acceptance is associated with increased death risk in patients with atrial fibrillation on oral anticoagulation
    Rusin, Gabriela
    Konieczynska, Malgorzata
    Natorska, Joanna
    Malinowski, Krzysztof Piotr
    Undas, Anetta
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (01) : 155 - 163
  • [22] Oral anticoagulation in the prevention of the risk of a thromboembolism in atrial fibrillation
    David, Claire
    Boinet, Tomas
    ACTUALITES PHARMACEUTIQUES, 2018, 57 (577): : 15 - 19
  • [23] Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation
    Steinberg, Benjamin A.
    Ballew, Nicholas G.
    Greiner, Melissa A.
    Lippmann, Steven J.
    Curtis, Lesley H.
    O'Brien, Emily C.
    Patel, Manesh R.
    Piccini, Jonathan P.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (12) : 1384 - 1392
  • [24] Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation
    Ferroni, Eliana
    Denas, Gentian
    Gennaro, Nicola
    Fedeli, Ugo
    Pengo, Vittorio
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [25] Gastrointestinal Bleeding During Direct Oral Anticoagulant Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of Polypharmacy
    Honda, Taku
    Abe, Koichiro
    Oda, Minoru
    Harada, Fumito
    Maruyama, Kyohei
    Aoyagi, Hitoshi
    Miura, Ryo
    Konno, Kumiko
    Arizumi, Toshihiko
    Asaoka, Yoshinari
    Kodashima, Shinya
    Kozuma, Ken
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (12): : 1548 - 1556
  • [26] Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (02) : 177 - 194
  • [27] Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding
    Mascarenhas, Daniel A. N.
    Farooq, Mohammad U.
    Ziegler, Paul D.
    Kantharia, Bharat K.
    EUROPACE, 2016, 18 (06): : 799 - 806
  • [28] Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
    Magnocavallo, Michele
    Bellasi, Antonio
    Mariani, Marco Valerio
    Fusaro, Maria
    Ravera, Maura
    Paoletti, Ernesto
    Di Iorio, Biagio
    Barbera, Vincenzo
    Della Rocca, Domenico Giovanni
    Palumbo, Roberto
    Severino, Paolo
    Lavalle, Carlo
    Di Lullo, Luca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 18
  • [29] Temporal Discordance of Atrial Fibrillation Burden With Major Bleeding and Intracranial Hemorrhage: Implications for Oral Anticoagulation Therapy
    Askari, Mariam
    Ziegler, Paul D.
    Fan, Jun
    Schmitt, Susan K.
    Turakhia, Mintu P.
    CIRCULATION, 2016, 134
  • [30] Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
    Meera Kapadia
    Pooja S. Jagadish
    Marcus Hutchinson
    Hong Lee
    The Egyptian Heart Journal, 75
12345